Login to Your Account



Pharma: Other News To Note


Monday, March 4, 2013
• H. Lundbeck A/S, of Copenhagen, Denmark, and Otsuka Pharmaceutical Co., Ltd., of Tokyo, said the FDA approved Abilify Maintena (aripiprazole) for extended-release injectable suspension, an intramuscular depot formulation for the treatment of schizophrenia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription